ADIPOQ and metabolic dysfunction-associated steatotic liver disease: In their study, T. Yatagai et al. (2003) demonstrated that low blood levels of adiponectin in men with T2DM were associated with the accumulation of visceral (rather than subcutaneous) fat [69], while N. Sandhya et al. (2010) revealed an association between increased oxidative stress and low adiponectin concentrations in NAFLD patients with and without T2DM [70].